Baxter Corporate Headlines http://www.baxter.com/ Corporate Headline for Baxter Healthcare en-us Professor Sir Michael G. Marmot Selected as 2008 Recipient of the William B. Graham Prize for Health Services Research http://www.baxter.com/about_baxter/news_room/news_releases/2008/05-07-08_graham_prize.html ARLINGTON, Va. and DEERFIELD, Ill., May 7, 2008 – In recognition of his lifelong achievements and contributions to the field of health services research, Professor Sir Michael G. Marmot, MBBS, MPH, PhD, FRCP, FFPHM, FMedSci, has been selected as the 2008 recipient of the William B. Graham Prize for Health Services Research. Baxter Healthcare Tue, 7 May 2008 0:0:0 CST Baxter's Board of Directors Declares Quarterly Dividend http://www.baxter.com/about_baxter/news_room/news_releases/2008/05-06-08_dividend.html Shareholders Re-elect Directors and Ratify Auditor at Annual Meeting Baxter Healthcare Mon, 6 May 2008 0:0:0 CST Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced http://www.baxter.com/about_baxter/news_room/downloads/04-17-08-gammagard_study.pdf Product Donation and Program Support Increases Access to Advanced Therapies for People with Hemophilia around the World Baxter Healthcare Wed, 17 April 2008 0:0:0 CST Baxter Honors World Hemophilia Day with Donation to World Federation of Hemophilia's Global Alliance for Progress http://www.baxter.com/about_baxter/news_room/news_releases/2008/04-17-08-world_hemophilia.html Product Donation and Program Support Increases Access to Advanced Therapies for People with Hemophilia around the World Baxter Healthcare Wed, 17 April 2008 0:0:0 CST Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook http://www.baxter.com/about_baxter/news_room/news_releases/2008/04-17-08-first_qtr_earnings.html DEERFIELD, Ill., April 9, 2008 — Baxter Healthcare Corporation today announced its V-Link Luer-activated device (LAD) with VitalShield protective coating, the first needleless intravenous (IV) connector to contain an antimicrobial coating, is now available for hospitals in the United States and Canada. Baxter Healthcare Wed, 17 April 2008 0:0:0 CST Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease http://www.baxter.com/about_baxter/news_room/downloads/04-15-08-gammagard_study.pdf DEERFIELD, Ill., April 9, 2008 — Baxter Healthcare Corporation today announced its V-Link Luer-activated device (LAD) with VitalShield protective coating, the first needleless intravenous (IV) connector to contain an antimicrobial coating, is now available for hospitals in the United States and Canada. Baxter Healthcare Mon, 15 April 2008 0:0:0 CST